This study, called the TRAC-AF Registry, is looking at how well AtriCure devices work in real-world settings for people with atrial fibrillation (an irregular heartbeat). It's an observational study, meaning researchers will collect information from your regular medical care. They are interested in patients who have had or are scheduled for certain heart procedures using AtriCure devices, including open concomitant surgical ablation, hybrid (convergent) ablation, totally thoracoscopic ablation, or left atrial appendage (LAA) exclusion. The main goals are to track how much atrial fibrillation you experience 6 months after your procedure and to record any side effects within one year. You can join if you are 18 or older and are willing to give your informed consent. The study aims to include up to 10,000 patients.

Study design

This is an observational study, not a clinical trial testing a new treatment. It plans to enroll up to 10,000 participants.

What's involved

There will be no additional visits or procedures beyond your standard medical care. You will be followed for up to ten years.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for up to ten years after their procedure. Specific outcomes will be measured at 6 months and 1 year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.